催化劑製藥 CPRX 深 滬
已收盤 02-06 16:00:00 美东时间
24.44
+0.530
+2.22%
華盛通- 最 高24.58
- 今 開24.27
- 成交量 103.11万股
- 最 低 23.73
- 昨 收 23.91
- 總市值 30.04亿
- 52周最高 26.58
- 市盈率 靜 18.63
- 換手率 0.84%
- 52周最低 19.05
- 委 比 72.94%
- 總股本 1.23亿
- 歷史最高 26.58
- 量 比 0.79
- 振 幅 3.55%
- 歷史最低 0.37
- 每 手 1
- 風險率 1.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Jim Cramer: Crane Is A 'Good' Company, Recommends Holding This Tech Stock
Jim Cramer recommended holding Texas Instruments (TXN) on CNBC's Mad Money, supported by an analyst's hold rating and raised price target. He also praised Crane Company (CR) and Catalyst Pharmaceuticals (CPRX) for their strong earnings.
01-15 01:26
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
Students from the University of Notre Dame are participating in a week-long biopharmaceutical learning program organized by Catalyst Pharmaceuticals. The inaugural Catalyst Advocacy Scholars Summit (CASS) focuses on exploring challenges and opportunities in delivering medicines for rare diseases. Selected students will engage with Catalyst colleagues to gain insights into patient advocacy and industry navigation, while the company benefits from f...
01-05 13:03
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX), a biopharmaceutical company focused on developing therapies for rare diseases, announced that its CEO Rich Daly and other executives will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, at 3:45pm PST. The presentation will be webcast and available on the company's website, www.catalystpharma.com, with a replay available for 30 days. Catalyst is recognized for its com...
2025-12-15 13:03
How Do Investors Really Feel About Catalyst Pharmaceuticals Inc?
Catalyst Pharmaceuticals Inc's (NYSE:CPRX) short interest as a percent of float...
2025-12-02 04:00
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
Catalyst Pharmaceuticals, Inc. announced that President and CEO Rich Daly, along with other management team members, will participate in Citi’s 2025 Global Healthcare Conference in Miami on December 2, 2025, at 1:00pm ET. The event will be webcast and available on the Company’s website, with a replay accessible for 30 days. Catalyst is a biopharmaceutical company focused on developing and commercializing treatments for rare diseases.
2025-11-18 13:03
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
Citigroup Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $33
Citigroup analyst Samantha Semenkow maintains Catalyst Pharmaceuticals (NASDAQ:CPRX) with a Buy and raises the price target from $31 to $33.
2025-11-08 04:53
Catalyst Pharmaceuticals Raises FY2025 Sales Guidance from $545.000M-$565.000M to $565.000M-$585.000M vs $562.053M Est
Catalyst Pharmaceuticals (NASDAQ:CPRX) raises FY2025 sales outlook from $545.000 million-$565.000 million to $565.000 million-$585.000 million vs $562.053 million estimate.
2025-11-06 05:18
Catalyst Pharmaceuticals Q3 Adj. EPS $0.68 Beats $0.33 Estimate, Sales $148.392M Beat $136.802M Estimate
Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.33 by 104.82 percent. This is a 19.3 percent increase over earnings of $0.57 per share
2025-11-06 05:18
